Stanford University


Showing 7,701-7,750 of 7,778 Results

  • Michael Zeineh

    Michael Zeineh

    Professor of Radiology (Neuroimaging and Neurointervention)

    BioDr. Michael Zeineh received a B.S. in Biology at Caltech in 1995 and obtained his M.D.-Ph.D. from UCLA in 2003. After internship also at UCLA, he went on to radiology residency and neuroradiology fellowship both at Stanford. He has been faculty in Stanford Neuroradiology since 2010. He spearheads many initiatives in advanced clinical imaging at Stanford, including clinical fMRI and DTI. Simultaneously, he runs a lab with the goal of discovering new imaging abnormalities in neurodegenerative disorders, with a focus on detailed microcircuitry in regions such as the hippocampal formation using advanced, multi-modal in vivo and ex vivo methods, with applications to neurodegenerative disorders such as Alzheimer’s disease and mild traumatic brain injury.

  • Jamie Zeitzer

    Jamie Zeitzer

    Professor (Research) of Psychiatry and Behavioral Sciences (Sleep Medicine)

    Current Research and Scholarly InterestsDr. Zeitzer is a circadian physiologist specializing in the understanding of the impact of light on circadian rhythms and other aspects of non-image forming light perception.
    He examines the manner in which humans respond to light and ways to manipulate this responsiveness, with direct application to jet lag, shift work, and altered sleep timing in teens. Dr. Zeitzer has also pioneered the use of actigraphy in the determination of epiphenomenal markers of psychiatric disorders.

  • Amanda Zerbe

    Amanda Zerbe

    Clinical Supervising Attorney and Lecturer in Law, Environmental Law Clinic

    BioAmanda Zerbe (she/her) is a Clinical Supervising Attorney at the Stanford Environmental Law Clinic. She joined Stanford Law School as an Early Career Climate Law Fellow in March 2023, where she worked closely with the Climate and Energy Policy Program and the Environmental and Natural Resources Law and Policy Program. She previously worked as a Legal Fellow at the Institute for Policy Integrity at New York University School of Law.

    Amanda graduated in 2021 from Stanford Law School with a joint M.S. degree from the Emmett Interdisciplinary Program in Environment and Resources (E-IPER) at Stanford University, where she was a Knight-Hennessy Scholar. During law school, she interned at Earthjustice and at the California Air Resources Board.

    Prior to law school, Amanda facilitated projects related to big data for development and climate action at the United Nations Global Pulse as a John Gardner Public Service Fellow. She also worked at the Flora Family Foundation. She holds bachelors’ degrees with distinction from Stanford University.

  • Bing Melody Zhang

    Bing Melody Zhang

    Clinical Associate Professor, Pathology

    Current Research and Scholarly InterestsMy main research interests lie in the following areas:
    1) HLA testing for BMT/solid organ transplantation
    2) NGS-based TCR/Ig clonality/MRD testing
    3) HLA testing in cellular therapy and oncology
    4) Genetic/genomic testing for malignant and non-malignant hematologic disorders
    5) HLA-related disease association/drug hypersensitivity testing.

  • C Pam Zhang

    C Pam Zhang

    Adjunct Professor

    BioC Pam Zhang is the author of two novels, How Much of These Hills Is Gold and Land of Milk and Honey. She is the winner of the Academy of Arts and Letters Rosenthal Award, the Asian/Pacific Award for Literature, and the California Book Award. Zhang is a National Book Foundation 5 Under 35 Honoree, and the recipient of fellowships from MacDowell, the New York Public Library’s Cullman Center, and the American Library in Paris. Her writing appears in Best American Short Stories, The Cut, The New Yorker, and The New York Times. Her work has been translated into twelve languages.

  • Fanglin Zhang, MD., PhD.

    Fanglin Zhang, MD., PhD.

    Clinical Associate Professor, Adult Neurology

    BioDr. Zhang is a Clinical Associate Professor of Neurology and Neurological Sciences at Stanford University, where she is dedicated to diagnosing and treating complex neurological disorders in both inpatient and outpatient settings. She is a board-certified, fellowship-trained neurologist and clinical neurophysiologist. Dr. Zhang prioritizes building strong partnerships with her patients, focusing on overcoming neurological diseases and enhancing their quality of life through patient-centered and evidence-based medicine. Her approach emphasizes collaboration and communication, ensuring that her patients are actively involved in their care and treatment plans.
    As a clinician educator, Dr. Zhang takes great pleasure in mentoring trainees. She serves as the site director for both the Stanford Neurology Residency Program and the Neurohospitalist Fellowship Program. Additionally, she is the Education Director at Stanford Health Care Tri-Valley Neurology.
    Dr. Zhang is passionate about conducting innovative clinical research, with her findings published in numerous peer-reviewed journals. She is also deeply committed to community service and global health, dedicating her time and expertise to initiatives that aim to improve health outcomes and access to care for diverse populations.

  • Hao Zhang

    Hao Zhang

    Instructor, Cardiovascular Institute

    BioI earned my M.D. from Peking Union Medical College, Tsinghua University. Subsequently, I completed my residency and served as a cardiac fellow at Fuwai Hospital, where I developed a strong foundation in the pathophysiology of cardiovascular diseases.

    As a postdoctoral researcher and instructor in Dr. Joseph Wu’s lab at Stanford, I established a protocol to derive cardiac fibroblasts (CFs) from human iPSCs, providing an unlimited source of cells for studying cardiac fibrosis. This method generates homogenous iPSC-derived CFs that remain quiescent yet responsive to profibrotic stimuli. Notably, this protocol played a crucial role in developing a multiscale drug discovery platform that integrates human iPSCs, 3D-engineered heart tissues, and animal models of heart failure. Using this platform, I discovered novel signaling pathways and therapeutic targets for cardiac fibrosis. My most recent work has been published in Cell (https://doi.org/10.1016/j.cell.2024.09.034).

  • Hao Zhang

    Hao Zhang

    Clinical Assistant Professor, Radiation Oncology - Radiation Physics

    BioHao Zhang is a Clinical Assistant Professor in the Department of Radiation Oncology at Stanford University. He earned his PhD in Biomedical Engineering from Stony Brook University, followed by a two-year postdoctoral fellowship at Johns Hopkins University. After completing his clinical physics training through the Stanford University Medical Physics Residency Program, he served as an Assistant Attending Physicist and Assistant Member at Memorial Sloan Kettering Cancer Center for five years.

    His research interests include the development of novel imaging techniques, mathematical modeling of imaging systems and their underlying physics, integration of sophisticated models into iterative or deep learning-based reconstruction methods, and the translation of these approaches to clinical applications in both diagnostic imaging and image-guided radiation therapy.

  • Huaiyu Zhang

    Huaiyu Zhang

    Clinical Assistant Professor, Medicine - Cardiovascular Medicine

    BioDr. Zhang obtained her MS in Neuroscience from the University of Southern California and earned her PhD in Clinical Psychology from Emory University. She completed both her predoctoral internship and postdoctoral fellowship at Emory University School of Medicine. Prior to joining Stanford in 2023, Dr. Zhang supported survivors of interpersonal violence at the University of California San Francisco Trauma Recovery Center for over seven years. Dr. Zhang embraces an integrative, contextualized, evidence-informed, and strength-based approach to teaching, supervision, and clinical care. She provides services in English and Mandarin.

  • Ke-You (Yoyo) Zhang

    Ke-You (Yoyo) Zhang

    Clinical Assistant Professor, Pediatrics - Gastroenterology

    BioDr. Ke-You "Yoyo" Zhang is a board-certified pediatric transplant hepatologist and clinical assistant professor at Stanford University School of Medicine. She serves as Medical Director of both the Intestinal Transplant Program at Lucile Packard Children’s Hospital and the Vascularized Composite Tissue Transplant Program at Stanford Hospital. Dr. Zhang specializes in pediatric intestinal and liver transplantation, with research interests at the intersection of transplant immunology, stem cell therapeutics, and precision medicine.

    A graduate of the University of Connecticut School of Medicine, Dr. Zhang completed her pediatrics residency and fellowships in pediatric gastroenterology and transplant hepatology at Stanford. She has authored numerous peer-reviewed publications on topics including pediatric liver and intestinal transplantation, acute rejection, and pancreatitis, and she is a frequent invited speaker at international conferences. Dr. Zhang also directs clinical trials advancing novel therapies for intestinal transplant patients and holds leadership roles in national transplant and hepatology societies.

    Her work is recognized with the 2025 Early Career Clinical Excellence Award from Stanford's Department of Pediatrics. Dr. Zhang is deeply committed to improving outcomes and quality of life for children with complex gastrointestinal and liver diseases through innovative, multidisciplinary care.

  • Lu Zhang

    Lu Zhang

    Winter CSP Instructor

    BioLu Zhang, Founder and Managing Partner of Fusion Fund, is a renowned Silicon Valley-based investor, a serial entrepreneur, and a Stanford Engineering alumna. With a strong technical background, Lu has extensive experience bringing a broad range of technologies to commercialization and deep domain expertise in AI in healthcare, Enterprise AI/Networks, Edge Computing, and Data Privacy.
    Prior to starting Fusion Fund, Lu was a serial entrepreneur and materials science researcher, which eventually led her to create Fusion Fund in 2015. Since then, Lu has built a distinguished eco system and established her reputation in the VC industry. She was honored as Young Global Leader by World Economic Forum (Davos), Silicon Valley Women of Influence, Best 25 Female early-stage investor by Business Insider, Featured Honoree of VC of Forbes 30 under 30 and Town & Country 50 Modern Swans - Entrepreneurship Influencer.
    Lu frequently speaks at conferences such as World Economic Forum (Davos), Future Investment Initiative (FII), Web Summit, SuperReturn, etc., and is an Instructor at Stanford University. Lu also serves as a board member of many portfolio companies, the Board Director of CommonSpirit Health Foundation, the Board and Chairwomen of the Youth Council of Future Science Award, and Jury Board of the Cartier Women Initiative and Young Leader Award. She holds an M.S. in Materials Science and Engineering from Stanford University.

  • Niushen Zhang

    Niushen Zhang

    Clinical Associate Professor, Adult Neurology

    BioDr. Niushen Zhang is a board-certified neurologist and Chief of the Headache and Facial Pain Division in the Department of Neurology. She has a special interest in developing personalized treatment plans for headache patients which incorporate the use of complementary and integrative medicine. She is the Chair of the Complementary and Integrative Medicine Special Interest Section of the American Headache Society (AHS). Her research interests include the connection between the gut microbiome and migraine and the impact of diet and nutrition on migraine. In addition, she participates in clinical trials of new headache treatments for migraine and cluster headache. Dr. Zhang is also actively involved in medical education. She is the Director of the Headache Fellowship Program at Stanford. She serves as the Co-Chair of the Headache Fellowship Directors Committee for the American Headache Society (AHS). She is also a curriculum developer for AHS's REACH Program. She spearheaded the design and creation of the AHS National Headache Fellowship Opportunities website which serves as a central resource for all headache fellowship applicants and promotes the AAN's unified fellowship application timeline.

    Dr. Zhang graduated from Yale University with a Bachelor of Science degree in Molecular, Cellular and Developmental Biology. She earned an MD from the New York University School of Medicine. She completed neurology residency and fellowship in headache and facial pain at Stanford University.

  • Tian Yi Zhang, MD, PhD

    Tian Yi Zhang, MD, PhD

    Assistant Professor of Medicine (Hematology)

    BioDr. Zhang is a board-certified hematologist. She is also an assistant professor of hematology at Stanford University School of Medicine. In addition to her medical degree, she holds a PhD in cellular and molecular immunology.

    In her clinical practice, she treats patients with all forms of hematological malignancies, offering specialized expertise in acute myeloid leukemia, including therapy-resistant cases. For each patient, she develops a personalized care plan encompassing novel treatment options.

    Her research activities include conducting early phase clinical trials, investigator initiated clinical trials (IITs), studying the immune repertoire in patients with myeloid malignancies, and exploring cholesterol metabolic dependencies of acute myeloid leukemia (AML).

    She was the recipient of an A.P. Giannini Foundation fellowship award, which supports innovative research. The award helped fund Dr. Zhang’s study of how AML cells interact with other cells in bone marrow. A significant finding confirmed that AML cells secrete a protein that suppresses the production of red blood cells, the same protein that causes inflammation in disorders such as rheumatoid arthritis and Crohn’s disease.

    Her many other honors include the National Cancer Institute Career Development (K08) Award, the American Society of Hematology (ASH) Research Training Award for Fellows, Stanford Cancer Institute - American Cancer Society (SCI-ACS) Pilot Grant and Best ASH Abstract Award two years in a row. She also has earned recognition from the National Institutes of Health and American College of Physicians.

    She has published her research findings on topics such as advanced therapy for high-risk myelodysplastic syndromes and reversal of bone marrow failure induced by AML. Her work has appeared in Leukemia & Lymphoma, Science Translational Medicine, Cancer Research, the Journal of Clinical Investigation, Journal of Immunology, and elsewhere.

    Dr. Zhang is a member of the American Association of Cancer Research and American Society of Hematology. She advises and mentors Stanford medical students, residents and fellows. She delivers invited lectures to faculty and fellows. In addition, she has been an invited speaker on the topic of acute myeloid leukemia at the Association of Northern California Oncologists Update on Hematological Malignancies.

  • Yu Zhang

    Yu Zhang

    Assistant Professor (Research) of Psychiatry and Behavioral Sciences (Public Mental Health and Population Sciences)

    BioDr. Yu Zhang's research operates at the intersection of AI, translational neuroscience, and precision medicine. His work focuses on unraveling the complex neurobiological mechanisms underlying cognitive deficits, behavioral dysfunctions, and therapeutic responses in mental health disorders. By integrating advanced machine learning techniques with multimodal brain imaging modalities (e.g., fMRI, DTI, EEG), Dr. Zhang aims to identify neural signatures that reveal the heterogeneity of mental disorders across individuals. A central goal of his research is the development and validation of robust neurobiomarkers to improve diagnostic accuracy, refine prognostic assessments, and guide personalized treatment strategies. His work systematically characterizes brain function and dysfunction to optimize therapeutic interventions, including pharmacological treatments, psychotherapy, and neurostimulation. He is particularly focused on conditions such as Alzheimer’s disease and related dimentia, mood disorders, and neurodevelopmental disorders (e.g., ADHD, ASD), where individualized approaches are essential for improving patient outcomes.

    Dr. Zhang has received several grants including the R01, R21, and Alzheimer's Association AARG grant. Beyond foundational research, Dr. Zhang is committed to bridging the gap between computational innovation and clinical application. By collaborating with clinicians, neuroscientists, and engineers, he strives to translate data-driven insights into actionable tools for real-world healthcare settings. His long-term vision is to enable mental health diagnostics and treatment to be guided by objective, biologically grounded biomarkers, thereby enhancing quality of life and long-term outcomes for individuals with psychiatric and neurological conditions.

    The Stanford Precision NeuroIntelligence (SPNI) Lab, led by Dr. Zhang, is dedicated to advancing research in AI-driven neuroimaging and precision psychiatry. The lab develops and applies cutting-edge machine learning and deep learning methods to uncover neurobiological mechanisms associated with cognitive and behavioral dysfunctions, as well as treatment responses in mental health conditions. Its mission is to identify translational biomarkers that support precision diagnosis, prognosis, and targeted interventions for mood disorders, neurodevelopmental disorders, and neurodegenerative diseases.

  • Haoqi (Nina) Zhao

    Haoqi (Nina) Zhao

    Acting Assistant Professor, Civil and Environmental Engineering

    BioNina will join Stanford CEE as an Assistant Professor in Summer 2026. Her research bridges computational metabolomics and exposomics to uncover unknown lifestyle chemicals and their impacts on health. Nina earned her B.S. from Peking University, her Ph.D. from the University of Washington, and is currently a postdoctoral scientist at UC San Diego. She received the Pathway to Independence Award (K99/R00) from the National Institutes of Health in 2025.

    The Zhao Lab at Stanford will operate at the interface of environmental chemistry, environmental health, and computational mass spectrometry. We aim to identify previously unrecognized chemical drivers that influence human and ecosystem health. We pursue this goal by developing innovative computational and analytical methods centered around untargeted mass spectrometry. Through these efforts, we aim to enable precision environmental health strategies, inform public health policies, and inspire sustainable chemical design.

    Current research interests include (but are not limited to):
    1.Leveraging mass spectrometry data repositories and advanced informatics tools to systematically map the chemical exposome.
    2.Developing tools and resources for mass spectrometry data analysis to advance exposomics research.
    3.Investigating host-microbiome-xenobiotic interactions and their impacts on human health.
    4.Integrating toxicology with untargeted screening to accelerate the discovery and risk assessment of unknown molecules.
    5.Pediatric environmental health: chemical exposures through breastfeeding and their implications for infant development.
    6.Traffic-related chemical pollution: environmental fate, occurrence, and relevance to human exposures.

    Education
    Ph.D., University of Washington, Environmental Engineering (2021)
    B.S., Peking University, Environmental Science (2016)

    Publications
    https://scholar.google.com/citations?user=xW9jBO0AAAAJ&hl=en

    Email: hqzhao@stanford.edu

  • Heng Zhao

    Heng Zhao

    Member, Wu Tsai Neurosciences Institute

    Current Research and Scholarly InterestsMy lab is focused on developing novel therapeutic methods against stroke using rodent models. We study protective effect of postconditioning, preconditioning and mild hypothermia. The rationale for studying three means of neuroprotection is that we may discover mechanisms that these treatments have in common. Conversely, if they have differing mechanisms, we will be able to offer more than one treatment for stroke and increase a patient’s chance for recovery.

  • Renee Zhao

    Renee Zhao

    Assistant Professor of Mechanical Engineering and, by courtesy, of Bioengineering and of Materials Science and Engineering

    BioRuike Renee Zhao is an Assistant Professor of Mechanical Engineering at Stanford University, where she directs the Soft Intelligent Materials Laboratory. Originally from the historic city of Xi'an, she earned her BS from Xi'an Jiaotong University in 2012. She then pursued Solid Mechanics at Brown University, obtaining her MS in 2014 and PhD in 2016. Following her doctoral studies, she completed postdoctoral training at MIT (2016–2018) before serving as an Assistant Professor at The Ohio State University (2018–2021).

    Renee’s research focuses on developing stimuli-responsive soft composites for multifunctional robotic systems with integrated shape-changing, assembly, sensing, and navigation capabilities. By integrating mechanics, material science, and advanced material manufacturing, her work enables innovations in soft robotics, miniaturized biomedical devices, robotic surgery, origami systems, active metamaterials, and general deployable morphing structures.

    Her contributions have been recognized with honors and awards, including the Presidential Early Career Award for Scientists and Engineers (PECASE), DARPA Young Faculty Award (YFA, 2025), ARO Early Career Program (ECP) Award (2023), AFOSR Young Investigator Research Program (YIP) Award (2023), Eshelby Mechanics Award for Young Faculty (2022), ASME Henry Hess Early Career Publication Award (2022), ASME Pi Tau Sigma Gold Medal (2022), ASME Applied Mechanics Division Journal of Applied Mechanics Award (2021), NSF CAREER Award (2020), and ASME Applied Mechanics Division Haythornthwaite Research Initiation Award (2018). She is also recognized as a National Academy of Sciences Kavli Fellow and was named one of MIT Technology Review's 35 Innovators Under 35.

  • Moss Zhao

    Moss Zhao

    Instructor, Neurosurgery

    BioDr. Moss Zhao is an Instructor at Department of Neurosurgery, Stanford University. He develops cutting-edge and clinically viable imaging technologies to improve the diagnosis and treatment of cerebrovascular diseases across the lifespan. His specific areas of expertise include physiological modeling, arterial spin labeling, Bayesian inference, PET/MRI, and artificial intelligence. His scientific contributions could significantly improve the early detection of strokes and dementia as well as enrich the knowledge of brain development in the first two decades of life.

    Dr. Zhao received his DPhil at St Cross College of University of Oxford under the supervision of Prof. Michael Chappell. As an alumni mentor, he supports the career development of students of his alma mater. Since 2016, he has presented his work to more than 3000 delegates at international conferences and held leadership positions in professional societies. His research and teaching are supported by the American Heart Association, the National Institutes of Health, and the European Cooperation in Science and Technology.

  • Xiaolin Zheng

    Xiaolin Zheng

    Professor of Mechanical Engineering, of Energy Science Engineering, Senior Fellow at the Precourt Institute for Energy and Professor, by courtesy, of Materials Science and Engineering

    BioProfessor Zheng received her Ph.D. in Mechanical & Aerospace Engineering from Princeton University (2006), B.S. in Thermal Engineering from Tsinghua University (2000). Prior to joining Stanford in 2007, Professor Zheng did her postdoctoral work in the Department of Chemistry and Chemical Biology at Harvard University. Professor Zheng is a member of MRS, ACS and combustion institute. Professor Zheng received the TR35 Award from the MIT Technology Review (2013), one of the 100 Leading Global Thinkers by the Foreign Policy Magazine (2013), 3M Nontenured Faculty Grant Award (2013), the Presidential Early Career Award (PECASE) from the white house (2009), Young Investigator Awards from the ONR (2008), DARPA (2008), Terman Fellowship from Stanford (2007), and Bernard Lewis Fellowship from the Combustion Institute (2004).

  • Yanhua Zheng

    Yanhua Zheng

    Lecturer

    BioYanhua Zheng is a native Cantonese Speaker with more than 10 years of experience in education. She immigrated to the US in 2014 and received her combined B.A. and Masters in Chinese from San Francisco State University, one of the nations top-ranked Chinese language programs. She now lives in Palo Alto with her son and her husband. Yanhua is also an avid reader, writer, and artist.

  • Maggie Zhou

    Maggie Zhou

    Instructor, Medicine - Oncology

    BioDr. Zhou is an Instructor in the Division of Oncology at Stanford University with an academic focus in sarcoma. She graduated from Yale University with a B.A. and double majored in economics and molecular, cellular, and developmental biology. She subsequently received her M.D. from Stanford University School of Medicine, where she completed her internal medicine residency and fellowship training.

    Her research interests center around the development of novel therapeutics, understanding pathophysiology of rare sarcoma subtypes, and evaluating the utility of circulating tumor DNA for assessing disease response and detecting minimal residual disease. She has co-authored over 20 peer-reviewed publications, including in Clinical Cancer Research and Nature Cell, and is an active member of the Sarcoma Clinical Trial Working Group in the Hoosier Cancer Research Network. Her research has been supported by the Chinese American Hematologist and Oncologist Network and Sarcoma Alliance for Research through Collaboration.

  • Margaret J. Zhou, MD, MS

    Margaret J. Zhou, MD, MS

    Clinical Assistant Professor, Medicine - Gastroenterology & Hepatology

    BioDr. Margaret Zhou is a board-certified, fellowship-trained gastroenterologist with Stanford Health Care. She also holds an appointment as clinical assistant professor at Stanford University School of Medicine.

    She specializes in therapeutic endoscopy with expertise in treating Barrett’s esophagus and disorders of the pancreas and bile duct. In particular, she offers advanced endoscopic interventions to prevent, detect, and manage gastrointestinal (GI) cancers. These interventions include endoscopic mucosal resection, endoscopic ablation, endoscopic retrograde cholangiopancreatography, and endoscopic ultrasound. She is also interested in the management of esophageal disorders such as gastroesophageal reflux disease.

    Dr. Zhou has published widely on improving the detection of precancerous lesions and cancers of the GI tract. She is particularly interested in prevention, early detection, and outcomes in Barrett’s esophagus, esophageal cancer, and stomach cancer. In addition, she has published on new technologies and the use of artificial intelligence in GI. Her research has been published in multiple journals including Clinical Gastroenterology and Hepatology; Clinical and Translational Gastroenterology; and Cancer Epidemiology, Biomarkers & Prevention.

    Dr. Zhou is an active member of multiple national GI societies. She currently serves on the American Gastroenterological Association (AGA) Clinical Guidelines Committee and AGA Trainee and Early Career Committee. She also serves as an Associate Editor for Evidence-Based GI, an American College of Gastroenterology (ACG) journal.

  • Wenhui Zhou

    Wenhui Zhou

    Adjunct Clinical Instructor, Radiology

    BioWenhui was born in Southeast China and then immigrated to the San Francisco Bay Area as a teenager. He attended the University of California, Davis under a Regent Scholarship, and graduated with highest honors in Biochemistry and Molecular Biology. Wenhui subsequently pursued training in medicine and translational research in the Medical Scientist Training Program (MSTP) at Tufts University. In the Laboratory of Dr. Charlotte Kuperwasser, Wenhui studied the regulation and function of transcription factors in triple-negative breast cancer with the goal of improving cancer diagnosis and therapeutics. Additionally, he pursued clinical research examining image-guided ablative therapy as a front-line treatment option for renal cancer under the mentorship of Dr. Ronald Arellano at Massachusetts General Hospital. Outside of his clinical and academic interests, Wenhui enjoys food, taking walks, listening to NPR, and spending time with family and friends.